CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | +50.0% | 1,585 | +107.2% | 0.00% | – |
| Q2 2023 | $2 | -60.0% | 765 | -31.3% | 0.00% | – |
| Q1 2023 | $5 | -37.5% | 1,114 | +42.6% | 0.00% | – |
| Q4 2022 | $8 | -100.0% | 781 | -61.6% | 0.00% | – |
| Q3 2022 | $19,000 | 0.0% | 2,036 | -2.2% | 0.00% | – |
| Q2 2022 | $19,000 | -24.0% | 2,081 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | -3.8% | 2,081 | -2.3% | 0.00% | – |
| Q4 2021 | $26,000 | +23.8% | 2,131 | +42.6% | 0.00% | – |
| Q2 2021 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q1 2021 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q4 2020 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q2 2020 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q1 2020 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q4 2019 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q3 2019 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q2 2019 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q1 2019 | $21,000 | – | 1,494 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,655,576 | $4,685,280 | 0.73% |
| Bain Capital Life Sciences Investors, LLC | 934,898 | $2,645,761 | 0.27% |
| FNY Investment Advisers, LLC | 35,000 | $99 | 0.12% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,764,201 | $4,992,689 | 0.11% |
| Ergoteles LLC | 358,275 | $1,013,918 | 0.05% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $239,220 | 0.04% |
| PDT Partners, LLC | 85,088 | $240,799 | 0.03% |
| PINNACLE ASSOCIATES LTD | 672,440 | $1,903,005 | 0.03% |
| Alpine Global Management, LLC | 34,014 | $96,260 | 0.03% |
| XTX Topco Ltd | 52,025 | $147,231 | 0.03% |